Etosafe ER Tablet
Prescription Required
Product introduction
Etosafe ER Tablet is a pain-relieving medicine. It effectively alleviates pain and inflammation in conditions like rheumatoid arthritis, osteoarthritis, and acute pain.
It is a non-steroidal anti-inflammatory drug (NSAID).
It is a non-steroidal anti-inflammatory drug (NSAID).
Uses of Etosafe Tablet ER
Benefits of Etosafe Tablet ER
In Pain relief
Etosafe ER Tablet belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for short-term relief of pain, inflammation, and swelling in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis.
Take it as it is prescribed to get the most benefit. Do not take more or for longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
Take it as it is prescribed to get the most benefit. Do not take more or for longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
Side effects of Etosafe Tablet ER
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Etosafe
- Visual disturbance
- Vomiting
- Stomach pain/epigastric pain
- Nausea
- Indigestion
- Dizziness
- Drowsiness
- Visual disorder
How to use Etosafe Tablet ER
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Etosafe ER Tablet is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Etosafe ER Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Etosafe ER Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Etosafe ER Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Etosafe ER Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
SAFE IF PRESCRIBED
Etosafe ER Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Etosafe ER Tablet may not be needed in these patients. Please consult your doctor.
Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Etosafe ER Tablet in patients with liver disease. Please consult your doctor.
What if you forget to take Etosafe Tablet ER?
If you miss a dose of Etosafe ER Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Etosafe ER Tablet
₹16.37/Tablet ER
Etova-ER 600 Tablet
Ipca Laboratories Ltd
₹19.95/tablet er
22% costlier
Etogesic ER Tablet
Zydus Cadila
₹19.77/tablet er
21% costlier
Etofree 600 ER Tablet
Lupin Ltd
₹19.95/tablet er
22% costlier
Toldin ER 600 Tablet
Torrent Pharmaceuticals Ltd
₹19.09/tablet er
17% costlier
Musran ER 600mg Tablet
Novartis India Ltd
₹13.89/tablet er
15% cheaper
Quick tips
- You have been prescribed Etosafe ER Tablet to relieve pain and inflammation.
- Take it with food or milk to prevent upset stomach.
- Take it as per the dose and duration prescribed by your doctor. Long term use may lead to serious complications such as stomach bleeding and kidney problems.
- It may cause dizziness, drowsiness or visual disturbances. Use caution while driving or doing anything that requires concentration.
- Avoid consuming alcohol while taking Etosafe ER Tablet as it can cause excessive drowsiness and increase your risk of stomach problems.
- Inform your doctor if you have a history of heart disease or stroke.
- Your doctor may regularly monitor your kidney function, liver function and levels of blood components, if you are taking this medicine for long-term treatment.
Fact Box
Chemical Class
Indolyl Carboxylic Acids Derivatives
Habit Forming
No
Therapeutic Class
PAIN ANALGESICS
Action Class
NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid)
Patient concerns
User feedback
Patients taking Etosafe ER Tablet
Once A Day
88%
Twice A Day
11%
Thrice A Day
1%
Thrice A week
1%
FAQs
Q. Is Etosafe ER Tablet a narcotic?
No, Etosafe ER Tablet is not a narcotic. It belongs to non-steroidal anti-inflammatory drugs (NSAIDs) group of medicines.
Q. Does Etosafe ER Tablet get you high?
No, Etosafe ER Tablet does not get you high. It does not have an abuse potential (drug-seeking behavior) and does not cause physical or psychological dependence. However, if you do not feel well, consult your doctor.
Q. Who should not use Etosafe ER Tablet?
Use of Etosafe ER Tablet should be avoided in patients who are allergic to Etosafe ER Tablet or any of its components. However, if you are not aware of any allergy or if you are using Etosafe ER Tablet for the first time, consult your doctor.
Q. Can Etosafe ER Tablet hurt your kidneys?
Long-term use and high doses of Etosafe ER Tablet may cause renal problems, such as protein or blood in urine and pain during urination. Patients who had or have heart failure, impaired kidney function and hypertension are at risk of kidney problems. The risk of developing kidney problems is also high in patients who are on medicines which cause excess urination (diuretics), or medicines which have significant impact on kidney function. Along with that, Etosafe ER Tablet can affect kidneys of patients who are above 65 years of age or who remain dehydrated. Therefore, kidney function monitoring is recommended for such patients.
Q. Does Etosafe ER Tablet make you drowsy?
Etosafe ER Tablet can cause drowsiness and also dizziness, fatigue (tiredness) and visual disturbances. However, it is not very common and may not affect everyone. If you experience these symptoms avoid driving or operating heavy machinery.
Q. Is Etosafe ER Tablet effective?
Etosafe ER Tablet is effective if used in the dose and duration advised by your doctor. Do not stop taking it even if you see improvement in your condition. If you stop using Etosafe ER Tablet too early, the symptoms may return or worsen.
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 627.
- Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 985-86.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 518.
Marketer details
Name: Wanbury Ltd
Address: Wanbury Limited , BSEL Techpark, 'B' Wing, 10th Floor, Sector 30-A, Opp. Vashi Railway Station, Vashi, Navi Mumbai - 400703, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹163.7
Inclusive of all taxes
10.0 tablet er in 1 strip
SOLD OUT
Notify me